(28 days)
IF4100 is intended to be used in symptomatic relief of chronic intractable pain, posttraumatic and post-surgical pain.
Not Found
I am sorry, but the provided text from the 510(k) K013813 letter does not contain the detailed information necessary to answer your request. The document is an FDA clearance letter for a medical device (Apex Medical IF 4100) and primarily focuses on its substantial equivalence to a predicate device for marketing purposes.
It lacks specifics on:
- Acceptance criteria and reported device performance: While the indications for use are mentioned, no performance metrics or acceptance criteria are listed.
- Study details: There is no description of any clinical or performance studies, including sample sizes, data provenance, expert qualifications, or ground truth establishment.
- MRMC comparative effectiveness study or standalone performance: These types of studies are not mentioned.
Therefore, I cannot extract the requested information from this document.
§ 882.1320 Cutaneous electrode.
(a)
Identification. A cutaneous electrode is an electrode that is applied directly to a patient's skin either to record physiological signals (e.g., the electroencephalogram) or to apply electrical stimulation.(b)
Classification. Class II (performance standards).